PD
OCUL icon

Point72 (DIFC)’s Ocular Therapeutix OCUL Stock Holding History

Point72 (DIFC)’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$382K Buy
32,643
+24,832
+318% +$297K 0.03% 326
2025
Q2 		$72.5K Buy
7,811
+2,734
+54% +$21.4K ﹤0.01% 981
2025
Q1 		$37.2K Buy
+5,077
New +$39K ﹤0.01% 1252
2024
Q2 		– Sell
-10,899
Closed -$99.2K – 1783
2024
Q1 		$99.2K Buy
+10,899
New +$77.3K ﹤0.01% 1093

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Point72 (DIFC)'s OCUL Position: Q3 2025 in Review

Point72 (DIFC) increased its Ocular Therapeutix (OCUL) stake by 318% in Q3 2025, buying an estimated $297K and bringing the position to 32,643 shares worth $382K. The position accounts for 0.03% of the portfolio, ranked #326.

Point72 (DIFC) first reported a position in OCUL in Q1 2024 and has held it in 4 quarters since. 216 funds tracked by Wall St. Rank hold OCUL as of Q3 2025.

  • Point72 (DIFC) held 32,643 shares of Ocular Therapeutix worth $382K as of Q3 2025.
  • Point72 (DIFC) bought 24,832 Ocular Therapeutix shares in Q3 2025, an estimated $297K.
  • Ocular Therapeutix made up 0.03% of Point72 (DIFC)'s portfolio in Q3 2025, its #326 holding.
  • Point72 (DIFC) first reported a position in Ocular Therapeutix in Q1 2024 and has held it in 4 quarters since.
  • 216 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.